
Robert E. Mons III
Board Member
Robert E. Mons III brings deep commitment to healthcare innovation, scientific advancement, and the strategic partnerships required to accelerate breakthroughs in diabetes research.
His career has been dedicated to bridging the worlds of science, industry, and philanthropy — championing research commercialization, building meaningful collaborations between academic and clinical institutions, and ensuring that scientific progress translates into real outcomes for patients.


